Fort Point Capital Partners LLC Hepion Pharmaceuticals, Inc. Transaction History

Fort Point Capital Partners LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	$1.14 - $1.58 $11,399 - $15,800	-10,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.39 - $2.1 $13,899 - $21,000	10,000 New	10,000 $15,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $45.7M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Fort Point Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Fort Point Capital Partners LLC with notifications on news.